Search Abstracts Program

Session 59   Poster Session Targeting the Viral Reservoir 4:30-6:30 pm 4E-F

Click on the to view the poster for an abstract.

404-T.	Reduction of Persistent HIV-1 Replication Using Cell-Reservoir Specific Anti-Retroviral Therapy B. Patterson*1, S. L. Becker2, J. Snidow3, B. Pobiner3, D. Grundhoefer1, and A. Landay4 1Children’s Mem. Hosp. and Northwestern Univ. Med. Sch., Chicago, IL.; 2Pacific Horizon Med. Group, San Francisco, CA; 3GlaxoSmithKline, Res. Triangle Park, NC; and 4Rush Med. Coll., Chicago, IL Add to Itinerary
405-T.	Residual HIV-1 Disease Eradication (RHIDE) Trial: An HIV-1 Reservoir Eradication Approach in Humans Using a Novel and Stimulatory Intensification Therapy R. J. Pomerantz*1, M. Otero1, G. Nunnari1, A. Malin1, C. Coates1, C. Dascenzo1, J. DeSimone1, T. Babinchak1, H. Zhang1, G. Dornadula1, D. Culnan1, J. Sullivan1, Y. Xu1, J. Stern2 , W. Cavert3, A. Haase3, and J. Kulkosky1 1Thomas Jefferson Univ., Philadelphia, PA; 2Pennsylvania Hosp., Philadelphia; and 3Univ. of Minnesota, Minneapolis Add to Itinerary
406-T.	The Effect on Specific Human Primary Cell Populations of Prostratin, an Inducer of Latent HIV Reservoirs J. Kulkosky*, J. Sullivan, M. Otero, D. Culnan, Y. Xu, and R. J. Pomerantz Thomas Jefferson Univ., Philadelphia, PA Add to Itinerary
407-T.	Course of HIV RNA in CD4+ and CD8+ Lymphocytes in HIV-Infected Patients Undergoing HAART as Determined by Ultrasensitive Fluorescence in Situ Hybridisation (UFISH) A. Rubbert*, A. Wöhrmann, D. Passon, A. Jütte, B. Salzberger, and G. Fätkenheuer. Univ. of Cologne, Germany Add to Itinerary

---